Bio-Rad Laboratories, Inc. BIO.B Issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value
Issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value?
- Bio-Rad Laboratories, Inc. (BIO.B) reported issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value of $3.4M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value changed year-over-year?
- Bio-Rad Laboratories, Inc.'s issuance of common stock and reissuance of treasury stock under equity incentive plans, net of forfeitures, value decreased by 20.9% year-over-year, from $4.3M to $3.4M.